Skip to main content

Advertisement

SpringerLink
Log in

Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure?

  • Clinical Trials Review
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Staessen JA, Wang JG: Characteristics of published, ongoing and planned outcome trials in hypertension. In Hypertension: a Companion to Brenner and Rector’s the Kidney. Edited by Oparil S, Weber M. Philadelphia: W.B. Saunders; 1999:341–359.

    Google Scholar 

  2. Wright JM, Lee CH, Chambers GK: Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ 1999, 161:25–32.

    PubMed  CAS  Google Scholar 

  3. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997, 157:2413–2446.

  4. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999, 17:151–183.

    Google Scholar 

  5. Ramsay L, Williams B, Johnson G, et al.: Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999, 13:569–592.

    Article  PubMed  CAS  Google Scholar 

  6. Hansson L, Lindholm LH, Ekbom T, et al.: Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999, 354:1751–1756.

    Article  PubMed  CAS  Google Scholar 

  7. Yusef S, Sleigh P, Bosch J, et al.: Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. N Engl J Med 2000, 342:145–153.

    Article  Google Scholar 

  8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000, 355:253–259.

  9. McMahon, S: Blood pressure and risk of cardiovascular disease. N Engl J Med 2000, 342:50–51.

    Article  Google Scholar 

  10. van den Hoogen PCW, Feskens EJM, Naglekerke NJD, et al.: The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 2000, 342:1–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UAB Vascular Biology & Hypertension Program, Room 1047 ZRB, 703 South 19th Street, 35294, Birmingham, AL, USA

    Stephen E. Bakir MD & Suzanne Oparil MD

Authors
  1. Stephen E. Bakir MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzanne Oparil MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bakir, S.E., Oparil, S. Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure?. Current Science Inc 2, 291–294 (2000). https://doi.org/10.1007/s11906-000-0012-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-000-0012-4

Keywords

Search

Navigation